Article in JCO precision oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Mariateresa FrascinoDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Irene SiracusaDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Beatrice BisantiDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Francesca RuzziLaboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.ORCID 0000-0001-9555-3166
Maria Sofia SempriniLaboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.ORCID 0000-0001-5013-6908
Hugo De JongeDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.ORCID 0000-0003-2777-4084
Andrea De GiglioMedical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.ORCID 0000-0002-0731-5721
Pier-Luigi LolliniLaboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.ORCID 0000-0003-1702-4108
Andrea ArdizzoniMedical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Arianna PalladiniDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.ORCID 0000-0001-6105-4895
Francesco GelsominoMedical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.ORCID 0000-0002-9204-1728
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
purposePatients with tumors harboring MATERIALS AND
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring · full record | OpenQuestion